HLA Epitope Matching in Kidney Transplantation: An Overview for the General Nephrologist

Matthew Sypek, Joshua Kausman, Steve Holt, Peter Hughes

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Rapid changes in tissue-typing technology, including the widespread availability of highly specific molecular typing methods and solid-phase assays for the detection of allele-specific anti-HLA antibodies, make it increasingly challenging to remain up to date with developments in organ matching. Terms such as epitopes and eplets abound in the transplantation literature, but often it can be difficult to see what they might mean for the patient awaiting transplantation. In this review, we provide the historical context for current practice in tissue typing and explore the potential role of HLA epitopes in kidney transplantation. Despite impressive gains in preventing and managing T-cell–mediated rejection and the associated improvements in graft survival, the challenge of the humoral alloresponse remains largely unmet and is the major cause of late graft loss. Describing HLA antigens as a series of antibody targets, or epitopes, rather than based on broad seroreactivity patterns or precise amino acid sequences may provide a more practical and clinically relevant system to help avoid antibody-mediated rejection, reduce sensitization, and select the most appropriate organs in the setting of pre-existing alloantibodies. We explain the systems proposed to define HLA epitopes, summarize the evidence to date for their role in transplantation, and explore the potential benefits of incorporating HLA epitopes into clinical practice as this field continues to evolve toward everyday practice.

LanguageEnglish
Pages720-731
Number of pages12
JournalAmerican Journal of Kidney Diseases
Volume71
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Human leukocyte antigen (HLA)
  • antibody-mediated rejection (AMR)
  • epitope
  • epitope matching
  • eplet
  • graft loss
  • graft survival
  • histocompatibility
  • kidney transplant
  • kidney transplantation
  • matching
  • molecular typing

ASJC Scopus subject areas

  • Nephrology

Cite this

Sypek, Matthew ; Kausman, Joshua ; Holt, Steve ; Hughes, Peter. / HLA Epitope Matching in Kidney Transplantation : An Overview for the General Nephrologist. In: American Journal of Kidney Diseases. 2018 ; Vol. 71, No. 5. pp. 720-731.
@article{21f403df2fb2446bacc6062ef40e666c,
title = "HLA Epitope Matching in Kidney Transplantation: An Overview for the General Nephrologist",
abstract = "Rapid changes in tissue-typing technology, including the widespread availability of highly specific molecular typing methods and solid-phase assays for the detection of allele-specific anti-HLA antibodies, make it increasingly challenging to remain up to date with developments in organ matching. Terms such as epitopes and eplets abound in the transplantation literature, but often it can be difficult to see what they might mean for the patient awaiting transplantation. In this review, we provide the historical context for current practice in tissue typing and explore the potential role of HLA epitopes in kidney transplantation. Despite impressive gains in preventing and managing T-cell–mediated rejection and the associated improvements in graft survival, the challenge of the humoral alloresponse remains largely unmet and is the major cause of late graft loss. Describing HLA antigens as a series of antibody targets, or epitopes, rather than based on broad seroreactivity patterns or precise amino acid sequences may provide a more practical and clinically relevant system to help avoid antibody-mediated rejection, reduce sensitization, and select the most appropriate organs in the setting of pre-existing alloantibodies. We explain the systems proposed to define HLA epitopes, summarize the evidence to date for their role in transplantation, and explore the potential benefits of incorporating HLA epitopes into clinical practice as this field continues to evolve toward everyday practice.",
keywords = "Human leukocyte antigen (HLA), antibody-mediated rejection (AMR), epitope, epitope matching, eplet, graft loss, graft survival, histocompatibility, kidney transplant, kidney transplantation, matching, molecular typing",
author = "Matthew Sypek and Joshua Kausman and Steve Holt and Peter Hughes",
year = "2018",
month = "5",
day = "1",
doi = "10.1053/j.ajkd.2017.09.021",
language = "English",
volume = "71",
pages = "720--731",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "5",

}

HLA Epitope Matching in Kidney Transplantation : An Overview for the General Nephrologist. / Sypek, Matthew; Kausman, Joshua; Holt, Steve; Hughes, Peter.

In: American Journal of Kidney Diseases, Vol. 71, No. 5, 01.05.2018, p. 720-731.

Research output: Contribution to journalReview article

TY - JOUR

T1 - HLA Epitope Matching in Kidney Transplantation

T2 - American Journal of Kidney Diseases

AU - Sypek, Matthew

AU - Kausman, Joshua

AU - Holt, Steve

AU - Hughes, Peter

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Rapid changes in tissue-typing technology, including the widespread availability of highly specific molecular typing methods and solid-phase assays for the detection of allele-specific anti-HLA antibodies, make it increasingly challenging to remain up to date with developments in organ matching. Terms such as epitopes and eplets abound in the transplantation literature, but often it can be difficult to see what they might mean for the patient awaiting transplantation. In this review, we provide the historical context for current practice in tissue typing and explore the potential role of HLA epitopes in kidney transplantation. Despite impressive gains in preventing and managing T-cell–mediated rejection and the associated improvements in graft survival, the challenge of the humoral alloresponse remains largely unmet and is the major cause of late graft loss. Describing HLA antigens as a series of antibody targets, or epitopes, rather than based on broad seroreactivity patterns or precise amino acid sequences may provide a more practical and clinically relevant system to help avoid antibody-mediated rejection, reduce sensitization, and select the most appropriate organs in the setting of pre-existing alloantibodies. We explain the systems proposed to define HLA epitopes, summarize the evidence to date for their role in transplantation, and explore the potential benefits of incorporating HLA epitopes into clinical practice as this field continues to evolve toward everyday practice.

AB - Rapid changes in tissue-typing technology, including the widespread availability of highly specific molecular typing methods and solid-phase assays for the detection of allele-specific anti-HLA antibodies, make it increasingly challenging to remain up to date with developments in organ matching. Terms such as epitopes and eplets abound in the transplantation literature, but often it can be difficult to see what they might mean for the patient awaiting transplantation. In this review, we provide the historical context for current practice in tissue typing and explore the potential role of HLA epitopes in kidney transplantation. Despite impressive gains in preventing and managing T-cell–mediated rejection and the associated improvements in graft survival, the challenge of the humoral alloresponse remains largely unmet and is the major cause of late graft loss. Describing HLA antigens as a series of antibody targets, or epitopes, rather than based on broad seroreactivity patterns or precise amino acid sequences may provide a more practical and clinically relevant system to help avoid antibody-mediated rejection, reduce sensitization, and select the most appropriate organs in the setting of pre-existing alloantibodies. We explain the systems proposed to define HLA epitopes, summarize the evidence to date for their role in transplantation, and explore the potential benefits of incorporating HLA epitopes into clinical practice as this field continues to evolve toward everyday practice.

KW - Human leukocyte antigen (HLA)

KW - antibody-mediated rejection (AMR)

KW - epitope

KW - epitope matching

KW - eplet

KW - graft loss

KW - graft survival

KW - histocompatibility

KW - kidney transplant

KW - kidney transplantation

KW - matching

KW - molecular typing

UR - http://www.scopus.com/inward/record.url?scp=85037732560&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2017.09.021

DO - 10.1053/j.ajkd.2017.09.021

M3 - Review article

VL - 71

SP - 720

EP - 731

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 5

ER -